We’ve hit a BIG milestone


Hi!

The T2B community recently reached a very exciting milestone:

Our membership is now 1,000-strong!

From 0 - 1000 in less than 18 months (we launched in October 2023). That’s pretty incredible.

Beyond the sheer growth, I continue to be impressed with the experience we have within our community. About half of our members have more than 15 years of experience, and two-thirds have over a decade of expertise.

And those comms rockstars have been absolutely vital in helping us develop the next generation of talent. Around a tenth of folks within T2B have fewer than three years of experience, and our veteran communicators have been inspirational in sharing advice to help our more junior members advance in their careers.

Our community also covers every corner of the biopharma comms sector in terms of employers – and this balance has, remarkably, held steady since day 1:

  • Roughly 40% of our members work in-house
  • Another 40% are employed in agencies or firms
  • The remaining 20% consists of independent practitioners, job seekers, students, and recent graduates

You can find full details of (in-house) organizations represented by our membership here.

As you can see, our membership is varied, which is why we’re already able to offer support, guidance, and development opportunities to biopharma comms pros from all areas of the industry.

But we’re not stopping there.

What’s next for T2B?

Biopharma comms is a niche community.

But that doesn’t mean it’s a small community.

Think about all of the communicators supporting every aspect of the global life science ecosystem. That’s a lot of people – there are so many of us out there.

(And that doesn’t even take into consideration emerging talent or people in adjacent industries who might be considering transitioning into our field in the near future.)

So we want to reach even more folks. More like-minded individuals who are passionate about advancing our profession.

And we’re making ourselves accountable by telling you that, in the future, we want to have a direct influence on there being:

  • A chief corporate affairs officer (or similar) on every in-house leadership team, in the same way that CSOs, CFOs, and CMOs are standard.
  • Established pathways for emerging talent. I want to hear about kids in high school and early college saying they want to be a biopharma communicator when they grow up.
  • A clear career path, plus the resources required for communicators to climb the career ladder, for those who want to follow it (alongside flexibility for progression for all kinds of communicators in our space).
  • Standardized competencies, so everyone knows what skillsets, knowledge, experience, etc., is expected at each career stage.

How can you help?

It doesn’t matter if you’re a comms veteran or a recent grad; part of a marketing team of one or a single cog in a huge department; or from a tiny start-up or a global organization. You are part of this, and we’ll be stronger with your support!

  • Shout from the rooftops about T2B! Share our emails, amplify our LinkedIn posts, and encourage your peers to sign up as members so we can reach even more passionate biopharma communicators.
  • Become a T2B Pro member. In order for T2B to continue to support our industry, we need to be a growing and evolving community. That’s why we created T2B Pro: to secure our future and make our model sustainable. Join us on that mission and sign up for T2B Pro.
  • Partner with us. Our sponsors make it possible for us to go further, faster. From leading life science companies to standout agencies and service providers, we’re proud to partner with organizations including Takeda, Weber Shandwick, Servier, Kura Oncology, AbbVie, Fullintel, and Waterhouse. Reply to this email to find out about how your organization can also become a T2B community champion.

To all of you who have joined us and supported us on the journey so far: thank you.

To those of you who will join us in the future; we can’t wait to have you on board.

Lynnea

T2B Monthly

Read more from T2B Monthly

Hi! The outcomes of the annual American Society of Clinical Oncology (ASCO) meeting will flood the media landscape with clinical updates, milestone announcements, and analyst notes. So biopharma comms pros and storytellers must understand how to stand out during one of healthcare’s most concentrated news moments. Enter the Q2 Media Minds Panel: Oncology Reporting and ASCO Coverage. “Top-Tier Perspective on ASCO and Beyond: How to Stand Out During Concentrated News Moments” is happening...

Hi! Last week, the T2B community tackled the topic of trust. In an intriguing and very candid Comm Convo led by speakers Kris Baum (former FDA, CDER), Mary Kosinski (FleishmanHillard), and Sarah Spencer (Vor Bio), we explored how the relationships we build shape our ability to lead, influence, and respond. With so many specific anecdotes and practical tips shared, it was hard to narrow down to just 10 key takeaways, but we managed it (barely!): Leverage science as your trust anchor. When...

Hi! We’re all about bringing together the most creative minds in biopharma in a bid to secure and enhance the future of our profession. One of the many ways we do this is through our roundtables, which are driven directly by members who specialize in, and are passionate about, key areas of biopharma communications. And the next discipline on that roster is patient advocacy and engagement. Everything you need to know about the Patient Advocacy and Engagement Roundtable This roundtable will...